Mesothelioma Treatment Options: A Comprehensive Guide

Treatment for mesothelioma has evolved significantly, offering patients more options than ever before. From traditional approaches like surgery and chemotherapy to cutting-edge immunotherapy and targeted treatments, understanding your options is essential for making informed decisions about your care.

Multimodal Treatment Approach

The most effective mesothelioma treatment typically involves a multimodal approach—combining two or more treatment types to attack the cancer from multiple angles. This strategy has shown improved survival rates compared to single-modality treatments.

Why Combination Therapy Works

  • Comprehensive attack: Different treatments target cancer cells in different ways
  • Reduced resistance: Cancer cells are less likely to develop resistance to multiple therapies simultaneously
  • Local and systemic control: Surgery and radiation address local tumors, while chemotherapy and immunotherapy target cancer throughout the body

Treatment planning involves a multidisciplinary team including thoracic surgeons, medical oncologists, radiation oncologists, and palliative care specialists working together to create an individualized approach.

Surgical Treatment Options

Surgery for mesothelioma aims to remove as much cancerous tissue as possible. Eligibility depends on cancer stage, tumor location, cell type, and overall patient health.

Pleural Mesothelioma Surgery

Extrapleural Pneumonectomy (EPP):

This aggressive surgery removes the affected lung, the pleura (lung lining), portions of the diaphragm, and the pericardium (heart lining). EPP is typically offered to patients with early-stage disease who can tolerate the procedure.

  • Best candidates: Younger patients with epithelioid cell type, no lymph node involvement
  • Potential benefits: Greatest chance of complete tumor removal
  • Risks: Significant surgical risks, permanent loss of one lung
  • Recovery: Extended hospital stay and rehabilitation period

Pleurectomy with Decortication (P/D):

This lung-sparing procedure removes the pleura and visible tumors while preserving the lung. P/D has become increasingly preferred over EPP due to lower mortality rates and comparable survival outcomes.

  • Best candidates: Patients with good lung function, early to mid-stage disease
  • Benefits: Preserves lung function, faster recovery than EPP
  • Considerations: May not remove all microscopic disease

Peritoneal Mesothelioma Surgery

Cytoreductive Surgery (CRS):

This extensive surgery removes visible tumors from the abdominal cavity. It is typically combined with HIPEC (see below) and has dramatically improved survival rates for peritoneal mesothelioma patients.

Diagnostic and Palliative Procedures

Even when curative surgery isn't possible, procedures can improve quality of life:

  • Thoracentesis: Drains fluid from around the lungs to relieve breathing difficulties
  • Pleurodesis: Seals the pleural space to prevent fluid reaccumulation
  • Pericardiocentesis: Drains fluid from around the heart
  • Paracentesis: Drains fluid from the abdominal cavity

Chemotherapy for Mesothelioma

Chemotherapy uses powerful drugs to kill cancer cells or stop them from dividing. It can be used as a primary treatment, before surgery (neoadjuvant), after surgery (adjuvant), or for palliative care.

First-Line Chemotherapy

The standard first-line treatment combines:

  • Pemetrexed (Alimta): An antifolate drug specifically approved for mesothelioma
  • Cisplatin: A platinum-based chemotherapy drug

This combination has been shown to extend survival by approximately 3 months compared to cisplatin alone and remains the gold standard for systemic treatment.

Administration and Side Effects

Chemotherapy is typically administered intravenously in cycles (usually every 21 days) over several months. Common side effects include:

  • Nausea and vomiting (managed with anti-nausea medications)
  • Fatigue
  • Low blood cell counts (increased infection risk)
  • Loss of appetite
  • Kidney damage (with cisplatin)

HIPEC (Heated Intraperitoneal Chemotherapy)

For peritoneal mesothelioma, HIPEC delivers heated chemotherapy directly to the abdominal cavity immediately after cytoreductive surgery. The heat helps the chemotherapy penetrate tissues more effectively.

  • Survival benefit: Median survival extended to 50+ months in selected patients
  • Procedure: Chemotherapy is circulated in the abdomen for up to 2 hours at 104-107°F
  • Benefits: Direct contact with cancer cells, limited systemic side effects

Second-Line and Experimental Chemotherapy

When first-line treatment stops working, options include:

  • Gemcitabine with or without cisplatin
  • Vinorelbine
  • Clinical trials of novel drug combinations

Radiation Therapy

Radiation therapy uses high-energy X-rays or particles to destroy cancer cells. While not typically curative on its own, radiation plays important roles in multimodal treatment and symptom management.

Types of Radiation Therapy

External Beam Radiation Therapy (EBRT):

The most common form, delivering radiation from outside the body using a linear accelerator. Modern techniques allow precise targeting:

  • IMRT (Intensity Modulated Radiation Therapy): Shapes radiation beams to match tumor contours, sparing healthy tissue
  • 3D-CRT (3D Conformal Radiation Therapy): Uses imaging to create three-dimensional treatment plans

When Radiation is Used

  • After surgery: To kill remaining cancer cells (adjuvant therapy)
  • Preventing recurrence: Along incision sites after EPP to prevent tumor seeding
  • Palliative care: To shrink tumors causing pain or breathing difficulties
  • Symptom relief: Reducing chest pain, controlling bleeding

Side Effects

Radiation side effects depend on the treatment area but may include:

  • Fatigue
  • Skin irritation at treatment site
  • Cough or shortness of breath (for chest radiation)
  • Nausea (for abdominal radiation)
  • Difficulty swallowing (if esophagus is in treatment field)

Immunotherapy

Immunotherapy represents one of the most promising advances in mesothelioma treatment, helping the body's immune system recognize and attack cancer cells.

Checkpoint Inhibitors

These drugs block proteins that prevent immune cells from attacking cancer:

  • Pembrolizumab (Keytruda): Blocks PD-1 protein; approved for certain mesothelioma cases after chemotherapy
  • Nivolumab (Opdivo): Also targets PD-1; used alone or with ipilimumab
  • Ipilimumab (Yervoy): Blocks CTLA-4; often combined with nivolumab

The combination of nivolumab and ipilimumab received FDA approval for unresectable mesothelioma in 2020, marking a significant milestone in immunotherapy treatment. Read about promising immunotherapy trials showing expanded treatment options.

How Immunotherapy Works

Cancer cells can evade immune detection by expressing proteins that bind to immune cell checkpoints, effectively "turning off" the immune response. Checkpoint inhibitors block this interaction, allowing T-cells to recognize and attack cancer cells.

Side Effects

Immunotherapy side effects differ from chemotherapy and may include:

  • Fatigue
  • Skin rash
  • Diarrhea
  • Thyroid problems
  • Immune-related adverse events (when the immune system attacks healthy organs)

CAR T-Cell Therapy (Investigational)

A highly personalized treatment involving modification of patient's own T-cells to better recognize mesothelioma cells. Currently available only through clinical trials but showing early promise.

Emerging and Experimental Treatments

Ongoing research continues to explore new treatment approaches:

Targeted Therapy

Drugs that target specific genetic mutations or cellular processes in cancer cells:

  • Anti-angiogenesis drugs: Prevent tumors from forming new blood vessels
  • EGFR inhibitors: Target epidermal growth factor receptors

Gene Therapy

Experimental approaches using viruses to deliver therapeutic genes directly to tumors or modifying patient cells to fight cancer.

Photodynamic Therapy (PDT)

Uses light-sensitive drugs that become active when exposed to specific light wavelengths, killing cancer cells while sparing healthy tissue. Often used during surgery.

Cryotherapy and Radiofrequency Ablation

Minimally invasive techniques to destroy small tumors using extreme cold (cryotherapy) or heat (radiofrequency ablation).

Tumor Treating Fields (TTFields)

A wearable device (Optune) delivering low-intensity electric fields that disrupt cancer cell division. FDA-approved for mesothelioma in combination with chemotherapy.

Finding the Right Treatment Team

As new treatments continue to emerge, it's important to work with specialists experienced in mesothelioma care. Consider finding a mesothelioma doctor or seeking a second opinion from another specialist to ensure you have access to the latest treatment options tailored to your specific diagnosis and stage.

Palliative Care

Palliative care focuses on improving quality of life by managing symptoms and providing support. It is appropriate at any stage of disease and can be provided alongside curative treatments.

Palliative Treatment Options

Importance of Early Palliative Care

Research shows that early integration of palliative care improves quality of life, reduces depression, and may even extend survival compared to delayed palliative care.

Financial Assistance for Treatment

The costs of mesothelioma treatment—including surgery, chemotherapy, immunotherapy, and supportive care—can be substantial. If you developed mesothelioma due to asbestos exposure, you may be eligible for financial compensation through lawsuits, settlements, or trust funds. Learn about mesothelioma compensation options and speak with a mesothelioma lawyer to understand how recovered funds can help cover treatment costs and provide financial security for your family.

Frequently Asked Questions About Treatment

What is the most effective treatment for mesothelioma?

There is no single "best" treatment—effectiveness depends on cancer stage, cell type, location, and patient health. Multimodal treatment combining surgery, chemotherapy, and radiation has shown the best survival outcomes for eligible patients. Emerging immunotherapy combinations are showing promise for advanced disease.

Can mesothelioma be cured with surgery?

Surgery alone rarely cures mesothelioma because microscopic cancer cells often remain. However, when combined with chemotherapy and/or radiation (multimodal therapy), surgery can significantly extend survival. Some patients treated aggressively have survived 5-10 years or longer.

How long does mesothelioma treatment last?

Treatment duration varies by approach. Chemotherapy typically involves 4-6 cycles over 3-4 months. Surgery requires several weeks of recovery. Radiation is usually given daily over 4-6 weeks. Many patients receive multiple treatments sequentially over months or years.

Is immunotherapy better than chemotherapy for mesothelioma?

Neither is universally "better"—they work differently and are often used at different stages. Chemotherapy remains first-line treatment for most patients. Immunotherapy is typically used after chemotherapy stops working or for patients who cannot tolerate chemotherapy. Some patients respond exceptionally well to immunotherapy.

Are there clinical trials for mesothelioma?

Yes, numerous clinical trials are investigating new treatments including novel immunotherapy combinations, targeted therapies, gene therapy, and treatment sequencing strategies. Participation in clinical trials provides access to cutting-edge treatments and contributes to research. Discuss trial options with your oncology team.

Your Next Steps

After learning about treatment options, here are important resources to guide your journey:

Ready to Take Action?

Understanding mesothelioma treatment options is the first step. The next step is connecting with a specialist who can create a personalized treatment plan. Don't delay—early treatment often leads to better outcomes.

Find a Mesothelioma Doctor Today

Sources & References

  1. NCCN Clinical Practice Guidelines: Malignant Pleural Mesothelioma
  2. NCI: Mesothelioma Treatment (Adult)
  3. Vogelzang NJ, et al. Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma. J Clin Oncol. 2003;21(14):2636-2644
  4. Baas P, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743). Lancet. 2021;397(10272):375-386
  5. ACS: Treating Malignant Mesothelioma